InterCure Ltd. (INCR)
NASDAQ: INCR · IEX Real-Time Price · USD
2.600
+0.070 (2.77%)
At close: Apr 23, 2024, 3:59 PM
2.570
-0.030 (-1.15%)
After-hours: Apr 23, 2024, 7:58 PM EDT
InterCure Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for InterCure.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for InterCure.
Recommendation Trends
| Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +92.31% | Apr 12, 2023 |
| Barclays | Barclays | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 11, 2017 |
| Credit Suisse | Credit Suisse | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 14, 2017 |
| Keybanc | Keybanc | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 13, 2017 |
| Baird | Baird | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 10, 2017 |
Financial Forecast
Revenue This Year
384.26M
from 388.68M
Decreased by -1.14%
Revenue Next Year
341.81M
from 384.26M
Decreased by -11.05%
EPS This Year
-0.44
from 0.99
EPS Next Year
-1.51
from -0.44
Revenue Forecast
| Revenue | 2023 | 2024 |
|---|---|---|
| High | 395.6M | 351.9M |
| Avg | 384.3M | 341.8M |
| Low | 369.2M | 328.4M |
Revenue Growth
| Revenue Growth | 2023 | 2024 |
|---|---|---|
| High | 1.8% | -8.4% |
| Avg | -1.1% | -11.0% |
| Low | -5.0% | -14.5% |
EPS Forecast
| EPS | 2023 | 2024 |
|---|---|---|
| High | -0.45 | -1.55 |
| Avg | -0.44 | -1.51 |
| Low | -0.42 | -1.45 |
EPS Growth
| EPS Growth | 2023 | 2024 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.